#USA #Leesburg #Centrifuge #Haier Biomedical #Resonant Clinical Solutions

A Breakthrough in Clinical Equipment

In a significant step towards environmental sustainability in clinical trials, Resonant Clinical Solutions and Haier Biomedical have officially launched the innovative LX-60T100R centrifuge. This new benchtop centrifuge utilizes a natural refrigerant, making it a pioneering solution tailored for clinical trials while also addressing rigid environmental regulations surrounding greenhouse gas (GHG) emissions.

Partnership for Innovation

This cutting-edge product is a result of a strategic partnership between Resonant Clinical Solutions, a global leader in clinical solutions, and Haier Biomedical, renowned for its reliable and sustainable laboratory equipment. Their collaboration has harnessed technical expertise and user-centric design to create a centrifuge that not only meets but exceeds regulatory requirements ahead of upcoming changes in both Europe and the United States regarding fluorinated gases.

The LX-60T100R centrifuge is tailored specifically for clinical testing environments, integrating advanced features designed to minimize environmental impact while enhancing usability. By utilizing hydrocarbons as refrigerants, the device drastically lowers the global warming potential (GWP) compared to traditional systems that rely heavily on fluorinated gases. Notably, the GWP has decreased from over 1,400 in older models to approximately 3 in the LX-60T100R, representing a monumental shift in laboratory equipment sustainability without sacrificing cooling performance.

Christophe Berthoux, CEO of Resonant Clinical Solutions, emphasizes the importance of this development: "Our goal is to deliver top-tier, client-centered solutions throughout the lifecycle of complex clinical trial programs. This redesigned centrifuge powered by a natural refrigerant stands as a testament to our commitment to innovation, responding to regulatory standards and market demand ahead of time."

Key Features of LX-60T100R

The LX-60T100R comes packed with innovative features:

• - Natural Hydrocarbon Refrigerant (R290): This smart choice significantly reduces environmental impact while maintaining effective cooling.
• - Rapid Pre-cooling: Achieving 4 °C from ambient temperature in about five minutes, it minimizes waiting times associated with traditional refrigerated centrifuges.
• - Versatile Speed Profiles: Tailored rotor speeds fit clinical trial procedures, accommodating various blood collection tubes and other containers.
• - 7-inch LCD Touch Screen: Offering responsive multi-point controls, even with gloves, along with rotor RFID recognition and user-access controls for improved usability.
• - Integrated Safety Monitoring: Features include vibration detection, imbalance control, and rotor lifespan tracking, ensuring reliability and safety during operation.
• - Compact and Quiet Operation: Weighing only 46 kg and operating at a low noise level of 52 dB(A), it’s designed for shared laboratory environments.

Enhancing Clinical Trial Efficiency

By launching this centrifuge, Resonant Clinical Solutions aims to address the needs of pharmaceutical sponsors and contract research organizations (CROs). The LX-60T100R supports compliance with upcoming regulatory changes while bolstering corporate sustainability initiatives. As an essential tool for clinical trials, its implementation can lead to more efficient workflows while simultaneously reducing the ecological footprint of laboratory operations.

Gang Liu, co-CEO of Haier Biomedical, echoes this sentiment, stating, "Our ability to turn concepts into innovative products in such a short time showcases our commitment to supporting our clients. As new challenges emerge in the biomedical sector, we remain dedicated to collaborating with scientists to develop inventive solutions that advance our field."

Availability of the LX-60T100R

The LX-60T100R centrifuge is available exclusively through Resonant Clinical Solutions until November 2027. Interested parties can already place orders for the model operating at 220-240 V AC, which is ready for purchase or rental, while the 110 V AC model is expected to be released in the first quarter of 2027.

In conclusion, the introduction of the LX-60T100R marks a significant milestone in the realm of clinical equipment. As the demand for environmentally responsible solutions continues to rise, this centrifuge serves as a catalyst for broader change across the industry, promising to simplify centrifugation procedures in clinical environments while remaining attuned to sustainability goals. For more information, visit resonantclinical.com.